These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Classification of childhood white matter disorders using proton MR spectroscopic imaging. Bizzi A; Castelli G; Bugiani M; Barker PB; Herskovits EH; Danesi U; Erbetta A; Moroni I; Farina L; Uziel G AJNR Am J Neuroradiol; 2008 Aug; 29(7):1270-5. PubMed ID: 18483189 [TBL] [Abstract][Full Text] [Related]
24. Hypomyelination with atrophy of the basal ganglia and cerebellum: follow-up and pathology. van der Knaap MS; Linnankivi T; Paetau A; Feigenbaum A; Wakusawa K; Haginoya K; Köhler W; Henneke M; Dinopoulos A; Grattan-Smith P; Brockmann K; Schiffmann R; Blaser S Neurology; 2007 Jul; 69(2):166-71. PubMed ID: 17620549 [TBL] [Abstract][Full Text] [Related]
25. An update on the leukodsytrophies. Schiffmann R; Boespflüg-Tanguy O Curr Opin Neurol; 2001 Dec; 14(6):789-94. PubMed ID: 11723390 [TBL] [Abstract][Full Text] [Related]
26. Developmental splicing deregulation in leukodystrophies related to EIF2B mutations. Huyghe A; Horzinski L; Hénaut A; Gaillard M; Bertini E; Schiffmann R; Rodriguez D; Dantal Y; Boespflug-Tanguy O; Fogli A PLoS One; 2012; 7(6):e38264. PubMed ID: 22737209 [TBL] [Abstract][Full Text] [Related]
27. Identification of ten novel mutations in patients with eIF2B-related disorders. Ohlenbusch A; Henneke M; Brockmann K; Goerg M; Hanefeld F; Kohlschütter A; Gärtner J Hum Mutat; 2005 Apr; 25(4):411. PubMed ID: 15776425 [TBL] [Abstract][Full Text] [Related]
28. Progressive megalencephaly due to specific EIF2Bepsilon mutations in two unrelated families. Passemard S; Gelot A; Fogli A; N'Guyen S; Barnerias C; Niel F; Doummar D; Arbues AS; Mignot C; de Villemeur TB; Ponsot G; Boespflug-Tanguy O; Rodriguez D Neurology; 2007 Jul; 69(4):400-2. PubMed ID: 17646634 [No Abstract] [Full Text] [Related]
29. Vanishing white matter disease with a novel EIF2B5 mutation: A 10-year follow-up. Bektaş G; Yeşil G; Özkan MU; Yıldız EP; Uzunhan TA; Çalışkan M Clin Neurol Neurosurg; 2018 Aug; 171():190-193. PubMed ID: 29933199 [TBL] [Abstract][Full Text] [Related]
30. Update on genetic disorders affecting white matter. Kaye EM Pediatr Neurol; 2001 Jan; 24(1):11-24. PubMed ID: 11182276 [TBL] [Abstract][Full Text] [Related]
31. Childhood ataxia with CNS hypomyelination/vanishing white matter disease--a common leukodystrophy caused by abnormal control of protein synthesis. Schiffmann R; Elroy-Stein O Mol Genet Metab; 2006 May; 88(1):7-15. PubMed ID: 16378743 [TBL] [Abstract][Full Text] [Related]
32. eIF2B, a mediator of general and gene-specific translational control. Pavitt GD Biochem Soc Trans; 2005 Dec; 33(Pt 6):1487-92. PubMed ID: 16246152 [TBL] [Abstract][Full Text] [Related]
33. Acute neurological deterioration in ovarioleukodystrophy related to EIF2B mutations: pregnancy with oocyte donation is a potentially precipitating factor. Peter L; Niel F; Catenoix H; Jung J; Demarquay G; Petiot P; Rudigoz RC; Boespflug-Tanguy O; Ryvlin P; Mauguière F Eur J Neurol; 2008 Jan; 15(1):94-7. PubMed ID: 18005052 [TBL] [Abstract][Full Text] [Related]
34. A Japanese girl with an early-infantile onset vanishing white matter disease resembling Cree leukoencephalopathy. Takano K; Tsuyusaki Y; Sato M; Takagi M; Anzai R; Okuda M; Iai M; Yamashita S; Okabe T; Aida N; Tsurusaki Y; Saitsu H; Matsumoto N; Osaka H Brain Dev; 2015 Jun; 37(6):638-42. PubMed ID: 25457085 [TBL] [Abstract][Full Text] [Related]
35. [Non specific leukodystrophy. A new case of vacuolizing leukoencephalopathy with megalencephaly]. de Santos-Moreno MT; Campos-Castelló J Rev Neurol; 2002 Jan 1-15; 34(1):19-27. PubMed ID: 11988888 [TBL] [Abstract][Full Text] [Related]
36. Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL): assessment of the involved white matter tracts by MRI. Kassem H; Wafaie A; Abdelfattah S; Farid T Eur J Radiol; 2014 Jan; 83(1):191-6. PubMed ID: 24558666 [TBL] [Abstract][Full Text] [Related]
37. Mutations causing childhood ataxia with central nervous system hypomyelination reduce eukaryotic initiation factor 2B complex formation and activity. Richardson JP; Mohammad SS; Pavitt GD Mol Cell Biol; 2004 Mar; 24(6):2352-63. PubMed ID: 14993275 [TBL] [Abstract][Full Text] [Related]
38. A mouse model for eukaryotic translation initiation factor 2B-leucodystrophy reveals abnormal development of brain white matter. Geva M; Cabilly Y; Assaf Y; Mindroul N; Marom L; Raini G; Pinchasi D; Elroy-Stein O Brain; 2010 Aug; 133(Pt 8):2448-61. PubMed ID: 20826436 [TBL] [Abstract][Full Text] [Related]
39. Leukoencephalopathy with vanishing white matter: a review. Bugiani M; Boor I; Powers JM; Scheper GC; van der Knaap MS J Neuropathol Exp Neurol; 2010 Oct; 69(10):987-96. PubMed ID: 20838246 [TBL] [Abstract][Full Text] [Related]